Talis Biomedical (TLIS) Return on Assets ROA from the second quarter of 2024 to second quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Talis Biomedical Corporation  (NASDAQ: TLIS)


Talis Biomedical's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Talis Biomedical's ROA in the second quarter of 2024?
Talis Biomedical Corporation recorded a cumulative net loss of $-51 million during 12 months ending in the second quarter of 2024, resulting in a negative return on assets (ROA) of -63.9%.

However, within the Healthcare sector 694 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2024 quarter, so far to 4382, from total ROA ranking in the first quarter of 2024 at 4422.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Total Assets Change -39.15 % -38.8 % -40.75 % -40.18 % -42.01 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -51 -57 -62 -75 -86
Return On Assets (TTM) -63.9 % -63.24 % -60.6 % -64.76 % -64.7 %
TLIS's Total Ranking # 4382 # 4422 # 5065 # 4562 # 4662
Total Assets (TTM) in million 66 75 83 96 109
Seq. Total Assets Change -11.73 % -9.57 % -13.72 % -11.65 % -11.22 %
Seq. Net Income Change - - - - -

TLIS's 5 Years Annual ROA >> Back to TLIS Management Effectiveness >> Compare TLIS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 26
Sector # 695
Overall # 4305

Return On Assets Statistics
High Average Low
-49.8 %
-54.75 %
-57.16 %
(Jun 30 2022)   (Jun 30 2024)



  News about Talis Biomedical Corporation Return on Assets ROA

Talis Biomedical Corporation Faces Stock Sell-Off Amidst Restructuring and Bankruptcy Concerns

The shares of Talis Biomedical Corporation (NASDAQ: TLIS) have experienced a significant sell-off in recent trading sessions, plummeting by 49% to $4.58. This drastic decrease has raised concerns among investors and has been influenced by multiple news articles, including company board restructuring, potential bankruptcy filings, and negative market sentiment. This article will delve deeper into the reasons behind this sell-off, the company s financial performance, and the impact within the healthcare sector.Talis Biomedical s Board Restructuring and Potential Bankruptcy:On August 7, 2024, Talis Biomedical Corporation announced an upcoming board restructuring as well as the appointment of new directors. While such changes are often seen as a positive step towards enhancing corporate governance, they seem to have exacerbated investor concerns, leading to a sharp decline in the company s stock price. Additionally, the company updated investors on its potential bankruptcy filing, revealing that it is considering this option. The news of this potential bankruptcy significantly contributed to the plummeting share prices, causing the stock to decrease by over 50% during premarket trading.



Financial Statements
Talis Biomedical's Assets $ 66 million TLIS's Balance sheet
Talis Biomedical's Income $ -9 million Quarterly TLIS's Income Statement
TLIS's Income by Division See TLIS's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
FY
Y / Y Total Assets Change -40.75 % -44.96 % - - -
Total Assets in million 83 140 254 0 0
Y / Y Net Income Change - - - - -
Net Income in million -62 -113 -192 0 0
Annual Return On Assets -74.97 % -80.96 % -75.71 % - -

TLIS's 5 Years Annual ROA >> Back to TLIS Management Effectiveness >> Compare TLIS ROA to its Competitors



More Return On Assets Ratios
TLIS's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TLIS's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TLIS's Competitors
Subscribers only: Roa for Talis Biomedical's Suppliers
Subscribers only: Return On Assets for TLIS's Customers

You may also want to know
TLIS's Roi TLIS's Inventory Turnover Ratio TLIS's Growth Rates TLIS's Dividend Comparisons
TLIS's Profitability Ratios TLIS's Asset Turnover Ratio TLIS's Dividend Growth
TLIS's Roe TLIS's Valuation Ratios TLIS's Financial Strength Ratios TLIS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2024, within Healthcare Sector ROA

Date modified: 2026-08-29T17:43:13+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.